These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Maternal age and amniocentesis: should this be lowered to 30 years? Crandall BF; Lebherz TB; Tabsh K Prenat Diagn; 1986; 6(4):237-42. PubMed ID: 2944088 [TBL] [Abstract][Full Text] [Related]
10. [Report of 8 years' experience in the prenatal diagnosis of genetic defects. II. Results]. Weise W; Gabriel D Zentralbl Gynakol; 1984; 106(4):216-29. PubMed ID: 6711184 [TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. Simpson NE; Dallaire L; Miller JR; Siminovich L; Hamerton JL; Miller J; McKeen C Can Med Assoc J; 1976 Oct; 115(8):739-48. PubMed ID: 61796 [TBL] [Abstract][Full Text] [Related]
12. Risk of amniocentesis and laboratory findings in a series of 1500 prenatal diagnoses. Verjaal M; Leschot NJ; Treffers PE Prenat Diagn; 1981 Jul; 1(3):173-81. PubMed ID: 7346822 [TBL] [Abstract][Full Text] [Related]
13. Temporal changes in Ohio amniocentesis utilization during the first twelve years (1972-1983), and frequency of chromosome abnormalities observed. Naber JM; Huether CA; Goodwin BA Prenat Diagn; 1987; 7(1):51-65. PubMed ID: 2950387 [TBL] [Abstract][Full Text] [Related]
14. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study. Wald N; Cuckle H; Nanchahal K Prenat Diagn; 1989 Dec; 9(12):813-29. PubMed ID: 2483269 [TBL] [Abstract][Full Text] [Related]
15. Amniocentesis in the West Midlands: report on 1000 births. Webb T; Edwards JH; Cameron AH; Crawley JM; Hulten M; Rushton DI; Thompson RA J Med Genet; 1980 Apr; 17(2):81-6. PubMed ID: 6155469 [TBL] [Abstract][Full Text] [Related]
16. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome. Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504 [TBL] [Abstract][Full Text] [Related]
17. Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening. Am J Obstet Gynecol; 1989 Mar; 160(3):575-81. PubMed ID: 2467563 [TBL] [Abstract][Full Text] [Related]
19. Genetic amniocentesis: a six-years experience in an isolated region of northeastern Quebec (Canada). Hamel G; Simard L; Gagné R; De Braekeleer M Genet Couns; 1993; 4(2):103-8. PubMed ID: 7689325 [TBL] [Abstract][Full Text] [Related]
20. Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses. Sant-Cassia LJ; MacPherson MB; Tyack AJ Br J Obstet Gynaecol; 1984 Aug; 91(8):736-44. PubMed ID: 6380566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]